NASDAQ$BTTC

Black Titan Corp · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Headline financials

Total Revenue

$98K

Previous: $26.2K+273.6%
EPS (adj)

-$2.20

Previous: -$4.80+54.2%
Net Income

-$1.65M

Previous: -$33.1K-4896.2%
Operating Income

-$1.7M

Previous: -$46.9K-3514.9%
Gross Profit

$55K

Previous: $26.2K+109.7%
Cash & Equivalents

$1.14M

No prior period
Total Assets

$2.17M

No prior period
Stock-Based Comp

$290K

No prior period

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$98K

Q1 2023+273.6%vs Q1 2022
Beat estimate in 0 of 3 quarters(0%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro